These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 6608405

  • 1. In vivo administration of purified Jurkat-derived interleukin 2 in mice.
    Donohue JH, Lotze MT, Robb RJ, Rosenstein M, Braziel RM, Jaffe ES, Rosenberg SA.
    Cancer Res; 1984 Apr; 44(4):1380-6. PubMed ID: 6608405
    [Abstract] [Full Text] [Related]

  • 2. The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma.
    Donohue JH, Rosenstein M, Chang AE, Lotze MT, Robb RJ, Rosenberg SA.
    J Immunol; 1984 Apr; 132(4):2123-8. PubMed ID: 6607956
    [Abstract] [Full Text] [Related]

  • 3. In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2.
    Lotze MT, Frana LW, Sharrow SO, Robb RJ, Rosenberg SA.
    J Immunol; 1985 Jan; 134(1):157-66. PubMed ID: 3871099
    [Abstract] [Full Text] [Related]

  • 4. The fate of interleukin-2 after in vivo administration.
    Donohue JH, Rosenberg SA.
    J Immunol; 1983 May; 130(5):2203-8. PubMed ID: 6601147
    [Abstract] [Full Text] [Related]

  • 5. In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.
    Lotze MT, Matory YL, Ettinghausen SE, Rayner AA, Sharrow SO, Seipp CA, Custer MC, Rosenberg SA.
    J Immunol; 1985 Oct; 135(4):2865-75. PubMed ID: 2993418
    [Abstract] [Full Text] [Related]

  • 6. Interleukin 2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growth.
    Cheever MA, Thompson JA, Kern DE, Greenberg PD.
    J Immunol; 1985 Jun; 134(6):3895-900. PubMed ID: 3872906
    [Abstract] [Full Text] [Related]

  • 7. Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo.
    Cheever MA, Greenberg PD, Irle C, Thompson JA, Urdal DL, Mochizuki DY, Henney CS, Gillis S.
    J Immunol; 1984 May; 132(5):2259-65. PubMed ID: 6609193
    [Abstract] [Full Text] [Related]

  • 8. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 9. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G, Wu D, Wang Y, Cen J, Feng Y, Sun A, Tang X, Chang H, Zhu Z.
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [Abstract] [Full Text] [Related]

  • 10. Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma.
    Eberlein TJ, Rosenstein M, Spiess PJ, Rosenberg SA.
    J Natl Cancer Inst; 1982 Jul; 69(1):109-16. PubMed ID: 6980314
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Donor T cells can be induced to grow and survive long term in vivo without previous host immunosuppression.
    Chen W, Cheever MA.
    J Immunol; 1994 May 15; 152(10):4767-74. PubMed ID: 8176202
    [Abstract] [Full Text] [Related]

  • 13. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
    Hartmann F, Horak EM, Garmestani K, Wu C, Brechbiel MW, Kozak RW, Tso J, Kosteiny SA, Gansow OA, Nelson DL.
    Cancer Res; 1994 Aug 15; 54(16):4362-70. PubMed ID: 8044783
    [Abstract] [Full Text] [Related]

  • 14. Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2.
    Vallera DA, Taylor PA, Aukerman SL, Blazar BR.
    Cancer Res; 1993 Sep 15; 53(18):4273-80. PubMed ID: 8364923
    [Abstract] [Full Text] [Related]

  • 15. A two-part phase I trial of high-dose interleukin 2 in combination with soluble (Chinese hamster ovary) interleukin 1 receptor.
    McDermott DF, Trehu EG, Mier JW, Sorce D, Rand W, Ronayne L, Kappler K, Clancy M, Klempner M, Atkins MB.
    Clin Cancer Res; 1998 May 15; 4(5):1203-13. PubMed ID: 9607578
    [Abstract] [Full Text] [Related]

  • 16. High level expression of the homeobox gene HB24 in a human T-cell line confers the ability to form tumors in nude mice.
    Deguchi Y, Kehrl JH.
    Cancer Res; 1993 Jan 15; 53(2):373-7. PubMed ID: 8093351
    [Abstract] [Full Text] [Related]

  • 17. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA.
    Cancer Res; 2000 Dec 15; 60(24):6977-84. PubMed ID: 11156399
    [Abstract] [Full Text] [Related]

  • 18. In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy.
    Tomala J, Chmelova H, Mrkvan T, Rihova B, Kovar M.
    J Immunol; 2009 Oct 15; 183(8):4904-12. PubMed ID: 19801515
    [Abstract] [Full Text] [Related]

  • 19. Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression.
    Voronov E, Weinstein Y, Benharroch D, Cagnano E, Ofir R, Dobkin M, White RM, Zoller M, Barak V, Segal S, Apte RN.
    Cancer Res; 1999 Mar 01; 59(5):1029-35. PubMed ID: 10070959
    [Abstract] [Full Text] [Related]

  • 20. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007 Mar 01; 26 Suppl 1():3-106. PubMed ID: 17365137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.